Return to Article Details THE EFFICACY OF CONCURRENT CHEMORADIOTHERAPY WITH THE CISPLATIN – 5-FLUOROURACIL REGIMEN IN STAGE II, III ESOPHAGEAL CANCER PATIENTS Download Download PDF